United Asset Strategies Inc. Has $580,000 Stake in CVS Health Co. (NYSE:CVS)

United Asset Strategies Inc. increased its holdings in CVS Health Co. (NYSE:CVS) by 2.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,217 shares of the pharmacy operator’s stock after buying an additional 212 shares during the period. United Asset Strategies Inc.’s holdings in CVS Health were worth $580,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Livelsberger Financial Advisory acquired a new position in CVS Health during the third quarter valued at approximately $31,000. First Community Trust NA grew its stake in shares of CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after purchasing an additional 302 shares during the last quarter. Kathleen S. Wright Associates Inc. acquired a new position in CVS Health in the third quarter valued at $33,000. ORG Partners LLC lifted its holdings in CVS Health by 11,840.0% in the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after buying an additional 592 shares during the period. Finally, Oliver Lagore Vanvalin Investment Group lifted its holdings in CVS Health by 71.0% in the second quarter. Oliver Lagore Vanvalin Investment Group now owns 595 shares of the pharmacy operator’s stock valued at $35,000 after buying an additional 247 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Up 0.1 %

CVS opened at $56.46 on Friday. The company has a 50 day moving average of $59.70 and a 200 day moving average of $59.65. The company has a market cap of $71.03 billion, a PE ratio of 10.05, a price-to-earnings-growth ratio of 0.83 and a beta of 0.54. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping the consensus estimate of $1.73 by $0.10. The company had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. CVS Health’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same period last year, the firm earned $2.21 EPS. On average, sell-side analysts expect that CVS Health Co. will post 6.41 EPS for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.71%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health’s dividend payout ratio is presently 47.33%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on CVS shares. Barclays dropped their target price on shares of CVS Health from $82.00 to $75.00 and set an “overweight” rating on the stock in a report on Wednesday, October 23rd. Deutsche Bank Aktiengesellschaft dropped their target price on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a report on Friday, August 9th. TD Cowen upgraded shares of CVS Health from a “hold” rating to a “buy” rating and boosted their target price for the company from $59.00 to $85.00 in a report on Friday, October 4th. Mizuho dropped their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a report on Tuesday, October 1st. Nine equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $74.58.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.